Glossary
Practice Quizzes

35.5 Nervous System Disorders

5 min read•june 14, 2024

Neurodegenerative and neurodevelopmental disorders affect millions worldwide. These conditions, like Alzheimer's and autism, impact brain function and behavior. Understanding their causes, symptoms, and treatments is crucial for improving patient care and quality of life.

Mental illnesses, such as depression and anxiety, are common but often misunderstood. These disorders can significantly impact daily life and relationships. Effective treatments combine medication and therapy, offering hope for those affected and highlighting the importance of mental health awareness.

Neurodegenerative and Neurodevelopmental Disorders

Neurodegenerative disorders: causes and treatments

Top images from around the web for Neurodegenerative disorders: causes and treatments

  • Alzheimer's disease - Wikipedia View original

    Is this image relevant?

  • Neurodegenerative Disorders | Biology for Majors II View original

    Is this image relevant?

  • Alzheimer's disease - Wikipedia View original

    Is this image relevant?

1 of 3

Top images from around the web for Neurodegenerative disorders: causes and treatments

  • Alzheimer's disease - Wikipedia View original

    Is this image relevant?

  • Neurodegenerative Disorders | Biology for Majors II View original

    Is this image relevant?

  • Alzheimer's disease - Wikipedia View original

    Is this image relevant?

1 of 3
    • Characteristics
      • Progressive memory loss and cognitive decline occur over time
      • Difficulty with language, problem-solving, and spatial orientation impair daily functioning
      • Accumulation of and in the brain lead to neuronal damage and death
    • Causes
      • Genetic factors contribute to risk, including mutations in (amyloid precursor protein), (presenilin 1), and (presenilin 2) genes
      • Environmental factors such as head trauma, cardiovascular disease, and lifestyle factors (diet, exercise) may influence disease onset and progression
    • Treatments
      • like , , and increase levels to improve cognitive function
      • antagonist regulates activity to slow cognitive decline
      • Non-pharmacological interventions such as cognitive stimulation (puzzles, games) and physical exercise (walking, swimming) may improve quality of life
    • Characteristics
      • , rigidity, (slow movement), and postural instability affect motor function
      • Degeneration of dopaminergic neurons in the leads to deficiency
      • Presence of , abnormal aggregates of protein, is a hallmark of the disease
    • Causes
      • Genetic factors play a role, with mutations in (alpha-synuclein), (leucine-rich repeat kinase 2), and (parkin) genes increasing risk
      • Environmental factors such as exposure to pesticides (paraquat, rotenone) and head trauma may contribute to disease development
    • Treatments
      • , a precursor to dopamine, is combined with to prevent peripheral conversion of levodopa and increase brain dopamine levels
      • like and directly stimulate dopamine receptors to improve motor symptoms
      • involves surgical implantation of electrodes in the brain (, ) to regulate abnormal electrical signals

Autism vs ADHD: symptoms and causes

    • Symptoms
      • Persistent deficits in social communication and interaction manifest as difficulty with reciprocal conversation, reduced eye contact, and limited facial expressions
      • Restricted, repetitive patterns of behavior, interests, or activities may include repetitive motor movements (hand flapping), insistence on routines, and intense interests
      • Symptoms present from early childhood (typically before age 3) and impair everyday functioning in social, occupational, or other areas
    • Potential causes
      • Genetic factors contribute significantly, with mutations in (fragile X syndrome), (Rett syndrome), and genes linked to ASD
      • Environmental factors such as advanced parental age (>35 years) and prenatal exposure to certain medications () may increase risk
  • (ADHD)
    • Symptoms
      • Inattention presents as difficulty sustaining focus, distractibility, and poor organization skills
      • Hyperactivity manifests as excessive talking, fidgeting, and difficulty sitting still
      • Impulsivity leads to interrupting others, blurting out answers, and making hasty decisions without considering consequences
    • Potential causes
      • Genetic factors play a substantial role, with variations in dopamine () and () receptor genes associated with ADHD
      • Environmental factors like prenatal exposure to tobacco or alcohol and low birth weight (<2500 g) may increase risk
  • Comparison
    • Both ASD and ADHD are neurodevelopmental disorders that onset in childhood and have a strong genetic component
    • Environmental factors can influence the development of both disorders, but their specific contributions remain an active area of research
  • Contrast
    • ASD primarily affects social communication and interaction, while ADHD impacts attention, hyperactivity, and impulsivity
    • ASD symptoms are typically more severe and persistent than ADHD symptoms, often requiring more intensive interventions and support

Neurobiological Mechanisms in Nervous System Disorders

  • Neurotransmitter imbalances play a crucial role in various disorders, affecting signaling between neurons
  • The regulates the passage of substances into the brain, influencing drug efficacy and disease progression
  • allows the brain to adapt and reorganize, which can be both beneficial in recovery and detrimental in some disorders
  • is a common feature in many nervous system disorders, contributing to tissue damage and symptom progression
  • involves the progressive loss of structure or function of neurons, leading to cognitive and motor impairments
  • can disrupt normal neural communication, contributing to various neurological and psychiatric conditions
  • , caused by exposure to toxic substances, can lead to damage or death of neurons, affecting brain function

Mental Illnesses and Treatment Approaches

Mental illnesses: types and treatments

  • Depressive disorders
    • and are common types
    • Symptoms include persistent feelings of sadness, loss of interest in activities, changes in sleep and appetite, and thoughts of death or suicide
    • Treatments involve antidepressant medications like () and () that increase and norepinephrine levels
    • Psychotherapy approaches such as (identifying and changing negative thought patterns) and interpersonal therapy (improving communication skills) are also effective
  • Anxiety disorders
    • , , and phobias are prevalent types
    • Symptoms include excessive worry, restlessness, irritability, and physical symptoms like increased heart rate and sweating
    • Treatments use anti-anxiety medications such as () and to reduce anxiety symptoms
    • Psychotherapy techniques like cognitive-behavioral therapy (exposure to feared stimuli) and exposure therapy (gradual confrontation of fears) help manage anxiety
    • Characterized by alternating episodes of mania (elevated mood, increased energy, impulsivity) and depression
    • Treatments involve mood stabilizers like and valproic acid to regulate mood fluctuations
    • Antipsychotic medications () may be used to manage manic or mixed episodes
    • Psychotherapy approaches such as cognitive-behavioral therapy (identifying triggers) and psychoeducation (understanding the disorder) support medication management
    • Symptoms include delusions, hallucinations, disorganized speech and behavior, and negative symptoms like diminished emotional expression and avolition (lack of motivation)
    • Treatments rely on antipsychotic medications such as and to reduce psychotic symptoms
    • Psychosocial interventions like cognitive-behavioral therapy (reality testing) and social skills training improve daily functioning
  • (OCD)
    • Characterized by recurrent and intrusive thoughts (obsessions) and repetitive behaviors or mental acts (compulsions) aimed at reducing anxiety
    • Treatments use antidepressant medications like SSRIs (fluoxetine) and to regulate serotonin levels
    • Psychotherapy, particularly exposure and response prevention therapy (exposing to feared stimuli without engaging in compulsions), is highly effective for OCD

Key Terms to Review (77)

Acetylcholine: Acetylcholine is a neurotransmitter that plays a crucial role in transmitting signals between nerve cells and muscle cells. It is essential for muscle contraction and is involved in various functions within the nervous system, including memory and learning processes. Acetylcholine is synthesized in neurons and released at synapses, where it binds to receptors on target cells to propagate signals.
Alpha-synuclein: Alpha-synuclein is a protein found predominantly in the brain that plays a crucial role in synaptic function and neurotransmitter release. It is closely associated with neurodegenerative disorders, particularly Parkinson's disease, where it forms aggregates known as Lewy bodies, disrupting cellular function and leading to neuronal death.
Alprazolam: Alprazolam is a prescription medication that belongs to the benzodiazepine class, primarily used to treat anxiety disorders and panic attacks. It works by enhancing the effects of a natural chemical in the body known as gamma-aminobutyric acid (GABA), which has a calming effect on the nervous system. Due to its sedative properties, it plays a significant role in managing symptoms associated with nervous system disorders.
Alzheimer’s disease: Alzheimer's disease is a progressive neurodegenerative disorder that primarily affects memory and cognitive function. It is characterized by the accumulation of amyloid plaques and neurofibrillary tangles in the brain.
Alzheimer's disease: Alzheimer's disease is a progressive neurological disorder that primarily affects memory, thinking, and behavior, leading to severe cognitive decline over time. It is the most common cause of dementia, characterized by the accumulation of amyloid plaques and tau tangles in the brain, which disrupt neuron function and communication. This degeneration of neurons and the role of glial cells in supporting neuronal health are crucial to understanding the pathophysiology of this devastating disorder.
Amyloid plaques: Amyloid plaques are abnormal clusters of protein fragments that accumulate between nerve cells in the brain, primarily associated with neurodegenerative diseases like Alzheimer's. These plaques are formed when beta-amyloid peptides aggregate and misfold, disrupting cell function and leading to cognitive decline and neuronal death. Their presence is a hallmark of certain nervous system disorders, highlighting their critical role in understanding disease mechanisms.
APP: APP, or Amyloid Precursor Protein, is a transmembrane protein that plays a crucial role in neuronal growth, survival, and synaptic function. It is particularly important in the context of Alzheimer's disease, as its abnormal processing leads to the formation of amyloid-beta peptides, which aggregate to form plaques in the brains of affected individuals. Understanding APP and its metabolic pathways is vital for unraveling the molecular mechanisms behind various nervous system disorders.
Attention deficit hyperactivity disorder: Attention Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder characterized by patterns of inattention, hyperactivity, and impulsivity that can interfere with functioning or development. ADHD affects both children and adults and often coexists with other disorders, influencing various aspects of daily life, including academic performance, social interactions, and emotional well-being.
Attention deficit/hyperactivity disorder (ADHD): ADHD is a neurological disorder characterized by inattention, hyperactivity, and impulsiveness. It affects brain regions involved in executive function and behavior regulation.
Autism spectrum disorder: Autism spectrum disorder (ASD) is a complex neurodevelopmental condition characterized by challenges with social interaction, communication, and repetitive behaviors. It exists on a spectrum, meaning individuals can experience a wide range of symptoms and varying degrees of impairment, which can affect their everyday functioning and quality of life.
Autism spectrum disorder (ASD): Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder characterized by difficulties with social interaction, communication, and repetitive behaviors. It is called a 'spectrum' because symptoms and severity can vary widely.
Benzodiazepines: Benzodiazepines are a class of medications primarily used to treat anxiety, insomnia, and various other nervous system disorders. They work by enhancing the effects of the neurotransmitter gamma-aminobutyric acid (GABA) in the brain, leading to sedation, muscle relaxation, and reduced anxiety. These medications have become widely prescribed for their effectiveness, but their potential for dependence and withdrawal symptoms necessitates careful management.
Bipolar disorder: Bipolar disorder is a mental health condition characterized by extreme mood swings that include emotional highs (mania or hypomania) and lows (depression). These fluctuations can significantly affect a person's energy, activity levels, sleep patterns, and ability to think clearly. The condition is often associated with changes in brain chemistry and can impact various aspects of life, including relationships, work performance, and overall quality of life.
Blood-brain barrier: The blood-brain barrier (BBB) is a selective permeability barrier that separates the circulating blood from the brain and central nervous system (CNS), serving to protect the brain from potentially harmful substances while allowing essential nutrients to pass through. This unique feature is critical for maintaining the brain's stable environment and is formed by endothelial cells that are tightly packed together, along with supporting glial cells, particularly astrocytes. The BBB plays a key role in the function and health of neurons, as well as influencing various nervous system disorders.
Bradykinesia: Bradykinesia is a medical term that refers to the slowness of movement, which is a hallmark symptom of various neurological disorders, particularly Parkinson's disease. It is characterized by a noticeable decrease in the amplitude and speed of voluntary movements, making everyday activities challenging for those affected. This symptom often leads to difficulties with initiating movement, maintaining posture, and performing fine motor tasks.
Buspirone: Buspirone is an anxiolytic medication primarily used to treat generalized anxiety disorder (GAD). Unlike traditional benzodiazepines, buspirone does not cause sedation or dependency, making it a safer alternative for long-term treatment of anxiety. It works by affecting neurotransmitters in the brain, particularly serotonin and dopamine, which play crucial roles in mood regulation and anxiety.
Carbidopa: Carbidopa is a medication used primarily in the treatment of Parkinson's disease, functioning as a dopa decarboxylase inhibitor that prevents the conversion of levodopa to dopamine outside of the brain. By doing so, it enhances the effectiveness of levodopa, reducing the side effects and increasing its availability to cross the blood-brain barrier, which is crucial for managing symptoms associated with nervous system disorders.
Cholinesterase inhibitors: Cholinesterase inhibitors are a class of drugs that block the action of the enzyme acetylcholinesterase, which is responsible for breaking down the neurotransmitter acetylcholine in the synaptic cleft. By preventing the breakdown of acetylcholine, these inhibitors increase its availability and enhance cholinergic neurotransmission. This mechanism is particularly important in treating various nervous system disorders, including Alzheimer’s disease and myasthenia gravis, where enhancing acetylcholine activity can alleviate symptoms.
Clomipramine: Clomipramine is a tricyclic antidepressant primarily used in the treatment of obsessive-compulsive disorder (OCD) and depression. It works by inhibiting the reuptake of neurotransmitters, particularly serotonin and norepinephrine, which are crucial for mood regulation. The drug's effectiveness in treating OCD has made it significant in managing anxiety disorders and various neurological conditions.
Cognitive-Behavioral Therapy: Cognitive-behavioral therapy (CBT) is a type of psychological treatment that focuses on changing negative thought patterns and behaviors to improve emotional regulation and develop coping strategies. It is widely used for treating various mental health conditions, including anxiety disorders and depression, and involves structured sessions where patients learn to identify and challenge distorted thinking. CBT's effectiveness lies in its focus on the relationship between thoughts, feelings, and behaviors, making it particularly relevant in addressing nervous system disorders.
Deep Brain Stimulation: Deep brain stimulation (DBS) is a neurosurgical procedure that involves implanting electrodes in specific areas of the brain to modulate abnormal brain activity, primarily for the treatment of neurological disorders. This technique has shown promise in alleviating symptoms associated with conditions like Parkinson's disease, dystonia, and obsessive-compulsive disorder. By delivering electrical impulses, DBS can help restore more normal patterns of brain function and improve patients' quality of life.
Donepezil: Donepezil is a medication that is primarily used to treat Alzheimer's disease, working as a reversible inhibitor of the enzyme acetylcholinesterase. By increasing the levels of acetylcholine in the brain, it helps improve cognitive function and slow down the progression of symptoms associated with this type of dementia. Its role in managing Alzheimer's makes it significant in understanding how nervous system disorders can affect cognition and behavior.
Dopamine: Dopamine is a neurotransmitter that plays several important roles in the brain and body, including the regulation of mood, motivation, reward, and motor control. This chemical messenger is crucial for communication between neurons and is involved in both the central and peripheral nervous systems, influencing behavior and physical functions.
Dopamine agonists: Dopamine agonists are substances that activate dopamine receptors in the brain, mimicking the effects of dopamine, a crucial neurotransmitter involved in regulating mood, motivation, and motor control. These compounds are commonly used in the treatment of various nervous system disorders, especially Parkinson's disease and certain psychiatric conditions, as they can help to restore the balance of dopamine signaling in the brain.
DRD4: DRD4 is a gene that encodes the dopamine receptor D4, which is involved in the transmission of signals in the brain. Variations in this gene have been linked to several behaviors and psychological traits, influencing conditions such as ADHD and other nervous system disorders. Understanding DRD4 helps illuminate how genetic factors can affect neurological functioning and behavioral outcomes.
Epilepsy: Epilepsy is a neurological disorder characterized by recurrent, unprovoked seizures. These seizures are caused by abnormal electrical activity in the brain.
Fluoxetine: Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) primarily used as an antidepressant to treat major depressive disorder, obsessive-compulsive disorder, bulimia nervosa, and panic disorder. By increasing serotonin levels in the brain, fluoxetine helps improve mood, anxiety, and overall emotional well-being, making it a significant medication in the management of various nervous system disorders.
FMR1: FMR1 is a gene located on the X chromosome that plays a crucial role in the development of the nervous system, particularly in synaptic function and neuronal development. It is best known for its association with fragile X syndrome, which is the most common inherited form of intellectual disability and is characterized by developmental delays, anxiety, and social difficulties. Mutations or expansions in the FMR1 gene lead to reduced production of the fragile X mental retardation protein (FMRP), essential for normal brain function.
Galantamine: Galantamine is a reversible inhibitor of the enzyme acetylcholinesterase, primarily used in the treatment of mild to moderate Alzheimer's disease. By increasing the levels of acetylcholine in the brain, galantamine enhances cholinergic function, which is often impaired in patients with Alzheimer's. This improvement in neurotransmitter activity can lead to better cognitive functioning and a slowing of symptom progression.
Generalized Anxiety Disorder: Generalized Anxiety Disorder (GAD) is a mental health condition characterized by excessive and uncontrollable worry about various aspects of life, including work, health, and social interactions. This disorder often leads to physical symptoms like restlessness, fatigue, and difficulty concentrating. Understanding GAD is crucial in the realm of nervous system disorders as it highlights how anxiety can impact the brain and body's functioning.
Globus pallidus: The globus pallidus is a subcortical structure located in the basal ganglia of the brain, primarily involved in the regulation of voluntary movement and motor control. It plays a crucial role in coordinating motor activity by processing information from the cerebral cortex and the striatum, influencing the output to other parts of the brain that manage movement. Disturbances in the function of the globus pallidus are linked to various nervous system disorders, particularly those affecting movement.
Glutamate: Glutamate is an amino acid that serves as the primary excitatory neurotransmitter in the brain, playing a crucial role in synaptic transmission and plasticity. It is vital for processes such as learning and memory, influencing neuronal communication and overall brain function.
Levodopa: Levodopa is a medication used primarily to treat Parkinson's disease and works by replenishing dopamine levels in the brain. It is a precursor to dopamine and helps alleviate symptoms such as tremors, stiffness, and bradykinesia by increasing dopamine availability in the central nervous system. This is particularly important because Parkinson's disease is characterized by the degeneration of dopamine-producing neurons, leading to motor control issues.
Lewy bodies: Lewy bodies are abnormal aggregates of protein that develop inside nerve cells, primarily composed of alpha-synuclein. These structures are associated with various neurodegenerative diseases, particularly Parkinson's disease and dementia with Lewy bodies. Their presence in the brain is indicative of cellular dysfunction and contributes to the symptoms associated with these nervous system disorders.
Lithium: Lithium is a chemical element, represented by the symbol Li, that is widely used in the treatment of mood disorders, particularly bipolar disorder. It helps stabilize mood swings and is particularly effective in reducing the frequency and severity of manic episodes, connecting it closely to the management of certain nervous system disorders.
LRRK2: LRRK2 (Leucine-Rich Repeat Kinase 2) is a gene that encodes a protein involved in several cellular processes, including neuronal function and survival. Mutations in this gene are one of the most common genetic causes of Parkinson's disease, linking it to the dysfunction of the nervous system. Understanding LRRK2 is crucial in the context of neurodegenerative disorders as it plays a significant role in cellular signaling pathways and inflammatory responses that can impact neuronal health.
Major depression: Major depression is a severe mood disorder characterized by prolonged periods of sadness, loss of interest in activities, and various physical and emotional problems. It affects how you feel, think, and handle daily activities.
Major depressive disorder: Major depressive disorder is a mental health condition characterized by a persistent feeling of sadness or a lack of interest in previously enjoyable activities, significantly impacting daily functioning. This disorder affects the nervous system by altering neurotransmitter levels, particularly serotonin, norepinephrine, and dopamine, which can lead to symptoms such as fatigue, changes in appetite, and difficulty concentrating. The implications of this disorder extend beyond mood disturbance, affecting cognitive functions and overall quality of life.
MeCP2: MeCP2, or methyl CpG binding protein 2, is a protein that plays a crucial role in regulating gene expression in eukaryotic cells by binding to methylated DNA. This protein is essential for the development and functioning of the nervous system, and its mutations are linked to severe neurological disorders, particularly Rett syndrome. The connection between MeCP2 and both transcription regulation and nervous system disorders highlights its importance in cellular function and overall health.
Memantine: Memantine is a medication primarily used to treat moderate to severe Alzheimer's disease by acting as an NMDA receptor antagonist. This drug helps to improve cognitive function and slows down the progression of symptoms associated with Alzheimer's by modulating glutamate activity in the brain. Memantine is often used in combination with other treatments to enhance patient outcomes in those suffering from neurodegenerative disorders.
NET: NET, in the context of nervous system disorders, refers to Neuroendocrine Tumors, which are a diverse group of tumors that arise from neuroendocrine cells. These tumors can occur in various organs, including the pancreas, lungs, and gastrointestinal tract, and can produce hormones or hormone-like substances, leading to a range of symptoms. Understanding NET is essential for diagnosing and treating conditions related to abnormal hormone production and the impact on the nervous system.
Neurodegeneration: Neurodegeneration refers to the progressive loss of structure or function of neurons, which can lead to various neurological disorders. This process often results in the impairment of cognitive and motor functions, affecting daily life and overall health. Understanding neurodegeneration is crucial for identifying underlying causes, developing treatments, and managing diseases such as Alzheimer's and Parkinson's.
Neurodegenerative disorders: Neurodegenerative disorders are conditions characterized by the progressive degeneration of the structure and function of the nervous system. These disorders often lead to debilitating symptoms, including motor dysfunction and cognitive decline.
Neurofibrillary tangles: Neurofibrillary tangles are abnormal aggregations of hyperphosphorylated tau protein that accumulate inside neurons, primarily associated with neurodegenerative diseases such as Alzheimer's disease. These tangles disrupt cellular function, contributing to the degeneration of neurons and cognitive decline seen in affected individuals. Their presence is a hallmark of various nervous system disorders and is indicative of the severity of the disease process.
Neuroinflammation: Neuroinflammation refers to the inflammatory response within the brain or spinal cord, which occurs when the immune system reacts to injury, infection, or disease. This process involves the activation of glial cells, particularly microglia and astrocytes, leading to the release of inflammatory cytokines and chemokines. While neuroinflammation is a protective response, it can also contribute to the progression of various nervous system disorders, highlighting its complex role in brain health and disease.
Neuroplasticity: Neuroplasticity is the ability of the nervous system to adapt and reorganize itself by forming new neural connections throughout life. This process is crucial for learning, memory, and recovery from injuries, showing how the brain can change in response to experience and environmental factors. It highlights the dynamic nature of neurons and glial cells, which play essential roles in supporting these adaptations.
Neurotoxicity: Neurotoxicity refers to the damaging effects that certain substances can have on the nervous system, leading to dysfunction in neural activity and overall neurological health. These substances, which can be chemicals, biological agents, or environmental factors, can interfere with nerve cell function, cause cell death, and disrupt communication between neurons. Understanding neurotoxicity is crucial in studying various nervous system disorders as it highlights the impact of external agents on neurological function.
Neurotransmitters: Neurotransmitters are chemical messengers that transmit signals across a synapse from one neuron to another, facilitating communication within the nervous system. They play crucial roles in influencing a wide range of physiological and psychological processes, including mood, perception, and muscle control.
NMDA receptor: The NMDA receptor is a specialized type of glutamate receptor in the brain that plays a crucial role in synaptic plasticity and memory function. It is unique because it requires both ligand binding and membrane depolarization to activate, which makes it important for learning processes and the strengthening of synapses.
Norepinephrine: Norepinephrine is a neurotransmitter and hormone that plays a key role in the body's response to stress and regulates various physiological functions, including blood pressure and heart rate. It is produced in the adrenal medulla and released during stressful situations, enhancing alertness and readiness for action, making it essential in both nervous system responses and hormonal regulation.
Obsessive-compulsive disorder: Obsessive-compulsive disorder (OCD) is a mental health condition characterized by persistent, unwanted thoughts (obsessions) and repetitive behaviors or mental acts (compulsions) that an individual feels driven to perform. This disorder significantly impacts daily functioning and can be associated with various neurological factors, including alterations in brain circuitry and neurotransmitter imbalances.
Olanzapine: Olanzapine is an atypical antipsychotic medication primarily used to treat schizophrenia and bipolar disorder. It works by influencing various neurotransmitters in the brain, particularly dopamine and serotonin, which are key players in mood and perception regulation. By balancing these chemicals, olanzapine helps manage symptoms like hallucinations, mood swings, and agitation, thus playing a crucial role in the treatment of certain nervous system disorders.
Panic disorder: Panic disorder is a type of anxiety disorder characterized by recurrent and unexpected panic attacks, which are sudden periods of intense fear or discomfort that trigger severe physical reactions. This disorder can significantly impact a person’s daily life, leading to avoidance behaviors and a heightened fear of future attacks. Individuals may experience symptoms like heart palpitations, sweating, trembling, and feelings of impending doom, making it crucial to understand its effects on the nervous system.
Parkinson’s disease: Parkinson's disease is a progressive neurodegenerative disorder characterized by the loss of dopamine-producing neurons in the substantia nigra. It primarily affects movement, causing tremors, stiffness, and bradykinesia (slowness of movement).
Parkinson's disease: Parkinson's disease is a progressive neurological disorder that primarily affects movement, characterized by tremors, stiffness, and balance issues. It results from the degeneration of dopamine-producing neurons in the brain, leading to impaired motor control and a range of non-motor symptoms, connecting it to the broader context of nervous system disorders.
Persistent Depressive Disorder: Persistent depressive disorder, also known as dysthymia, is a chronic form of depression that lasts for at least two years in adults or one year in children and adolescents. This condition can significantly impact an individual's daily functioning, social interactions, and overall quality of life. Unlike major depressive disorder, the symptoms are often less severe but more enduring, making it challenging for individuals to regain a sense of normalcy and happiness.
Pramipexole: Pramipexole is a medication primarily used to treat Parkinson's disease and restless legs syndrome. It acts as a dopamine agonist, stimulating dopamine receptors in the brain to help improve motor function and reduce symptoms associated with these conditions.
PRKN: PRKN, also known as Parkin, is a gene that encodes a protein involved in the ubiquitin-proteasome system, which plays a crucial role in targeting damaged or unnecessary proteins for degradation. Mutations in the PRKN gene are associated with autosomal recessive juvenile parkinsonism, a form of Parkinson's disease that typically arises at a younger age. Understanding PRKN is important in the context of neurodegenerative diseases, as it helps to elucidate the mechanisms behind protein clearance and cellular homeostasis.
PSEN1: PSEN1, or Presenilin 1, is a gene that encodes a protein component of the gamma-secretase complex, which plays a critical role in the processing of amyloid precursor protein (APP). Mutations in PSEN1 are strongly associated with familial Alzheimer's disease, highlighting its importance in neurodegenerative disorders that affect the nervous system. Understanding PSEN1 provides insight into the molecular mechanisms behind Alzheimer's pathology and potential therapeutic targets.
PSEN2: PSEN2, or Presenilin 2, is a gene that encodes a protein crucial for the process of gamma-secretase, which is involved in the cleavage of amyloid precursor protein (APP). This protein is important for normal brain function and has been linked to Alzheimer's disease when mutations occur. Understanding PSEN2 is vital in studying the mechanisms behind neurodegenerative diseases and how alterations in this gene can lead to nervous system disorders.
Quetiapine: Quetiapine is an atypical antipsychotic medication primarily used to treat schizophrenia, bipolar disorder, and major depressive disorder. It works by affecting the levels of neurotransmitters in the brain, particularly serotonin and dopamine, which are key players in mood regulation and perception. By modulating these neurotransmitters, quetiapine can help alleviate symptoms associated with various nervous system disorders.
Risperidone: Risperidone is an atypical antipsychotic medication primarily used to treat schizophrenia, bipolar disorder, and irritability associated with autism. It works by balancing certain neurotransmitters in the brain, particularly dopamine and serotonin, which can help alleviate symptoms like hallucinations, mood swings, and agitation. As an important treatment option for various nervous system disorders, risperidone has become a standard choice in psychiatric care.
Rivastigmine: Rivastigmine is a medication used to treat mild to moderate dementia associated with Alzheimer's disease and Parkinson's disease. It works as a reversible inhibitor of the enzyme acetylcholinesterase, which is responsible for breaking down the neurotransmitter acetylcholine. By increasing levels of acetylcholine in the brain, rivastigmine can help improve cognitive function and memory, making it an important therapeutic option in managing certain nervous system disorders.
Ropinirole: Ropinirole is a medication primarily used to treat Parkinson's disease and restless legs syndrome by mimicking the effects of dopamine in the brain. This drug acts on dopamine receptors, specifically the D2 subtype, helping to improve motor control and reduce symptoms associated with these neurological disorders. Its role in managing these conditions is crucial as it can help enhance the quality of life for individuals affected by dopamine deficiency.
Schizophrenia: Schizophrenia is a chronic mental disorder characterized by delusions, hallucinations, and disorganized thinking. It significantly affects how a person feels, thinks, and behaves.
Schizophrenia: Schizophrenia is a chronic and severe mental disorder characterized by disturbances in thought processes, perceptions, emotional responsiveness, and social functioning. Individuals with schizophrenia often experience symptoms such as hallucinations, delusions, and disorganized thinking, which can significantly impair their ability to function in everyday life. Understanding schizophrenia is essential as it highlights the complexity of mental health disorders and the interplay between biological, psychological, and environmental factors.
Serotonin: Serotonin is a neurotransmitter that plays a crucial role in regulating mood, emotions, and various bodily functions such as sleep and appetite. It is primarily found in the brain, intestines, and blood platelets, acting as a chemical messenger between neurons. Its significance extends to both normal neurological functioning and the development of various nervous system disorders.
SHANK3: SHANK3 is a gene that encodes a protein involved in synaptic signaling and is crucial for the development and function of neurons. Mutations in this gene have been linked to various nervous system disorders, particularly those associated with autism spectrum disorders and intellectual disabilities, highlighting its importance in neurodevelopment and synaptic integrity.
SNCA: SNCA, or alpha-synuclein, is a protein that is abundant in the brain and plays a key role in synaptic function and neurotransmitter release. Abnormal aggregation of SNCA is closely linked to neurodegenerative disorders, particularly Parkinson's disease, where these aggregates form Lewy bodies, a hallmark of the disease. The relationship between SNCA and nervous system disorders highlights the importance of this protein in understanding the mechanisms underlying neurodegeneration.
SNRIs: SNRIs, or Serotonin-Norepinephrine Reuptake Inhibitors, are a class of medications used primarily to treat major depressive disorder and anxiety disorders. They work by increasing the levels of serotonin and norepinephrine in the brain, which can help improve mood and alleviate symptoms of depression and anxiety. This dual-action mechanism makes SNRIs particularly effective for individuals who may not respond well to selective serotonin reuptake inhibitors (SSRIs).
SSRIs: Selective serotonin reuptake inhibitors (SSRIs) are a class of medications commonly used to treat depression and anxiety disorders by increasing the levels of serotonin in the brain. These drugs work by blocking the reabsorption (or reuptake) of serotonin, allowing it to remain available in the synaptic cleft longer, which can enhance mood and emotional regulation. SSRIs have become one of the most prescribed types of antidepressants due to their efficacy and relatively favorable side effect profile.
Substantia nigra: The substantia nigra is a critical structure located in the midbrain that plays an essential role in movement control and the regulation of motor functions. It contains a high concentration of dopamine-producing neurons, which are vital for coordinating smooth and controlled movements. Dysfunction of the substantia nigra is closely associated with various nervous system disorders, especially Parkinson's disease, where the degeneration of its neurons leads to motor symptoms such as tremors and rigidity.
Subthalamic nucleus: The subthalamic nucleus is a small, lens-shaped structure located in the basal ganglia of the brain that plays a crucial role in motor control. It acts as a critical relay station, helping to modulate and regulate movement by influencing the activity of other basal ganglia components. Dysfunction or damage to this area is often associated with various nervous system disorders, particularly those that affect motor function, such as Parkinson's disease.
Synaptic dysfunction: Synaptic dysfunction refers to the impairment of communication between neurons at the synapse, which can disrupt the normal signaling processes of the nervous system. This dysfunction can lead to various neurological and psychiatric disorders, impacting cognition, mood, and motor control. Understanding synaptic dysfunction is crucial as it underlies many conditions affecting the nervous system, including neurodegenerative diseases and mental health disorders.
Tremors: Tremors are involuntary, rhythmic muscle contractions that lead to shaking movements in one or more parts of the body. They can occur at rest, during movement, or when the muscles are being used, and are often associated with various nervous system disorders that affect motor control and coordination.
Valproic acid: Valproic acid is a medication primarily used to treat epilepsy and bipolar disorder, and it can also be used to prevent migraines. It works by stabilizing electrical activity in the brain, which helps to reduce seizure frequency and mood swings. This compound has also been studied for its neuroprotective effects and its potential role in various nervous system disorders.
Venlafaxine: Venlafaxine is a prescription medication primarily used as an antidepressant, belonging to the class of serotonin-norepinephrine reuptake inhibitors (SNRIs). It works by increasing the levels of serotonin and norepinephrine in the brain, which helps improve mood and relieve anxiety. This makes venlafaxine a key player in treating various nervous system disorders, particularly major depressive disorder and generalized anxiety disorder.
© 2024 Fiveable Inc. All rights reserved.
AP® and SAT® are trademarks registered by the College Board, which is not affiliated with, and does not endorse this website.
Back
Glossary
Glossary
Next